Cargando…
On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients
Repurposing of medicines has gained a lot of interest from the research community in recent years as it could offer safe, timely, and affordable new treatment options for cancer patients with high unmet needs. Increasingly, questions arise on how new uses will be translated into clinical practice, e...
Autores principales: | Verbaanderd, Ciska, Rooman, Ilse, Meheus, Lydie, Huys, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006723/ https://www.ncbi.nlm.nih.gov/pubmed/32076405 http://dx.doi.org/10.3389/fphar.2019.01664 |
Ejemplares similares
-
Exploring new uses for existing drugs: innovative mechanisms to fund independent clinical research
por: Verbaanderd, Ciska, et al.
Publicado: (2021) -
ReDO_DB: the repurposing drugs in oncology database
por: Pantziarka, Pan, et al.
Publicado: (2018) -
Repurposing Drugs in Oncology (ReDO)—Propranolol as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2016) -
Overcoming Barriers to the Market Access of Biosimilars in the European Union: The Case of Biosimilar Monoclonal Antibodies
por: Moorkens, Evelien, et al.
Publicado: (2016) -
Sharing of Clinical Trial Data and Samples: The Cancer Patient Perspective
por: Broes, Stefanie, et al.
Publicado: (2020)